COVID, FDA and vaccine
Digest more
The FDA plans to limit access to certain high-risk groups and also told Pfizer and Moderna to update their warning labels about heart inflammation.
Dr. Peter McCullough testified Thursday at a Senate hearing on "The Corruption of Science and Federal Health Agencies: How Health Officials Downplayed and Hid Myocarditis and Other Adverse Events Associated with the COVID-19 Vaccines.
U.S. health officials knew about the risks of myocarditis from COVID-19 vaccines but downplayed the concern and delayed informing the public about the risks of taking the jab, according to a new Senate report released by Sen.
The US FDA may limit Covid-19 boosters to high-risk groups only, citing lack of efficacy in healthy individuals. Meanwhile, India reports fresh cases, with Kerala on alert.
Preliminary data from researchers in China suggest the NB.1.8.1 variant is not better at evading the immune system compared to other strains on the rise, but it does have a greater ability to bind to human cells, suggesting it could be more transmissible.
The House Judiciary Committee revealed Thursday that Pfizer’s former Global Head of Vaccines Research and Development, Dr. Philip Dormitzer, may have “conspired to withhold public
The United States has identified multiple cases of a new COVID-19 variant, NB.1.8.1, which has been associated with the recent spike in infections across China. According to a report in the CBS, the variant was detected through the CDC's airport screening program in international travelers arriving at airports in California,
The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.
1h
Daily Express US on MSNNew Covid variant lands in US after ripping through countries, killing some in TaiwanThe travelers with cases linked to the NB.1.8.1 variant have been arriving at airports in California, Washington state, Virginia and the New York City area, according to the CDC's